bpc-157 igf-1 BPC 157: Revolutionizing Tissue Repair and Healing in Clinical Practice FDA panel votes to ease

The evidence base is almost entirely preclinical: rodent models consistently show accelerated tissue repair, gut healing, and neurological protection, but human RCT data remains largely absent

The peptides discussed are not approved for human consumption, clinical diagnosis, treatment, or any form of in-vivo use outside of controlled research settings

Any peptide we provide is part of a supervised plan, sourced appropriately, and monitored over time

The data were reconstructed over a total angular range of 360.22, with an angular step of 0.310

The question that has never been formally answered is whether those mechanisms translate into measurable clinical benefit in humans under controlled conditions